NEWCASTLE, UK I April 25, 2025 I Iksuda Therapeutics (Iksuda), the developer of class leading, clinically validated antibody drug conjugates (ADCs) today announces that it will present three posters ...

Anti-IL1RAP ADC demonstrated potent anti-tumor efficacy and was well tolerated in pre-clinical models Anti-IL1RAP ADC targets ...

Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of 113 health care workers in Catalonia who were followed for three years.

Get Instant Summarized Text (Gist) A clinical trial demonstrated that cord blood-derived natural killer (NK) cells pre-complexed with the bispecific antibody AFM13 showed high efficacy in treating ...

State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang’An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Subcutaneous LCMV infection induces T H 1 cell ...

To start, can you tell us a little about your role at LabGenius Therapeutics and what excites you most about working on automation in antibody discovery? At LabGenius Therapeutics, I’m focused ...